Performance analysis of Kairos Pharma (KAPA)
Annual Return
Since Sep 16, 2024, KAPA has had an average annual return of -67.62%, underperforming the benchmark SPY, which returned +17.69% annual.
| 2026 | 2025 | 2024 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -54.08% | -53.28% | -41.54% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -6.44% | -8.85% | -7.69% | +1.07% | -9.85% | -24.66% | -15.04% | -54.08% | |||||
| 2025 | -5.92% | -16.78% | -21.32% | -13.39% | -24.78% | +16.24% | +26.95% | +49.97% | -13.33% | -3.42% | -26.21% | -14.84% | -53.28% |
| 2024 | -39.62% | -16.56% | +17.57% | -1.30% | -41.54% |
Drawdown analysis of Kairos Pharma (KAPA)
The maximum drawdown for the KAPA was -88.08%, occurring on Jul 17, 2026. This drawdown has not yet recovered.
The current KAPA drawdown is -87.46%.
Since Sep 16, 2024 KAPA has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -88.08% | Sep 16, 2024 | 459 | Jul 17, 2026 | Ongoing | Ongoing | Ongoing |